Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1272

May 20, 2021

Infectious-disease scientists at Canada’s high-security lab collaborated with China

Posted by in categories: biotech/medical, military

Scientists working at Canada’s highest-security infectious-disease laboratory have been collaborating with Chinese military researchers to study and conduct experiments on deadly pathogens.

Seven scientists in the special pathogens unit at the National Microbiology Laboratory (NML) in Winnipeg and Chinese military researchers have conducted experiments and co-authored six studies on infectious diseases such as Ebola, Lassa fever and Rift Valley fever. The publication dates of the studies range from early 2016 to early 2020.

The Globe and Mail has also learned that one of the Chinese researchers, Feihu Yan, from the People’s Liberation Army’s (PLA) Academy of Military Medical Sciences, worked for a period of time at the Winnipeg lab, a Level 4 facility equipped to handle some of the world’s deadliest diseases. This researcher is credited as a co-author on all six of the papers. However, on two of them, he is listed as being affiliated with both the Winnipeg lab and the military medical academy.

May 20, 2021

New Coronavirus Detected In Patients At Malaysian Hospital; The Source May Be Dogs

Posted by in category: biotech/medical

A previously unknown novel coronavirus capable of infecting people has been discovered in Borneo, says a team of researchers from Duke University.

May 20, 2021

No, Science Clearly Shows That COVID-19 Wasn’t Leaked From A Wuhan Lab

Posted by in categories: biotech/medical, science

It occurred naturally, and scientists know this for certain.

May 20, 2021

Dr Jamie L. Wells, MD — Director, Research Science Inst — Pediatrician, Medical Innovator, Educator

Posted by in categories: biotech/medical, bitcoin, business, education, health, policy, robotics/AI, science

Pediatrician, Medical Innovator, Educator — Dr. Jamie Wells, MD, FAAP — Director, Research Science Institute (RSI), Center for Excellence in Education, Massachusetts Institute of Technology (MIT) — Professor, Drexel University School of Biomedical Engineering, Science and Health Systems.


Dr. Jamie L. Wells, MD, FAAP, is an Adjunct Professor at Drexel University’s School of Biomedical Engineering, Science and Health Systems, where she has been involved in helping to spearhead the nation’s first-degree program focused on pediatric engineering, innovation, and medical advancement.

Continue reading “Dr Jamie L. Wells, MD — Director, Research Science Inst — Pediatrician, Medical Innovator, Educator” »

May 19, 2021

Study solves mystery of how amyloid beta forms in brain nerve cells

Posted by in categories: biotech/medical, neuroscience

In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta—the neurotoxin believed to be at the root of Alzheimer’s disease (AD)—forms in axons and related structures that connect neurons in the brain, where it causes the most damage. Their findings, published in Cell Reports, could serve as a guidepost for developing new therapies to prevent the onset of this devastating neurological disease.

Among his many contributions to research on AD, Rudolph Tanzi, Ph.D., vice chair of Neurology and co-director of the McCance Center for Brain Health at MGH, led a team in 1986 that discovered the first Alzheimer’s disease gene, known as APP, which provides instructions for making protein precursor (APP). When this protein is cut (or cleaved) by enzymes—first, beta secretase, followed by gamma secretase—the byproduct is amyloid beta (sometimes shortened to Abeta). Large deposits of amyloid beta are believed to cause neurological destruction that results in AD. Amyloid beta formed in the brain’s axons and nerve endings causes the worst damage in AD by impairing communication between nerve cells (or neurons) in the brain. Researchers around the world have worked intensely to find ways to block the formation of amyloid beta by preventing cleavage by beta secretase and gamma secretase. However, these approaches have been hampered by safety issues.

Despite years of research, a major mystery has remained. “We knew that Abeta is made in the axons of the brain’s nerve cells, but we didn’t know how,” says Tanzi. He and his colleagues probed the question by studying the brains of mice, as well as with a research tool known as Alzheimer’s in a dish, a three-dimensional cell culture model of the disease created in 2014 by Tanzi and a colleague, Doo Yeon Kim, Ph.D. Earlier, in 2013, several other MGH researchers, including neurobiologist Dora Kovacs, Ph.D. (who is married to Tanzi), and Raja Bhattacharyya, Ph.D., a member of Tanzi’s lab, showed that a form of APP that has undergone a process called palmitoylation (palAPP) gives rise to amyloid beta. That study indicated that, within the neuron, palAPP is transported in a fatty vesicle (or sac) known as a lipid raft. But there are many forms of lipid rafts.

May 19, 2021

Single fingerprint at crime scene detects class A drug use

Posted by in category: biotech/medical

The National Center of Excellence in Mass Spectrometry Imaging at NPL, in collaboration with the University of Surrey and Ionoptika Ltd reveal latest findings showing how a single fingerprint left at a crime scene could be used to determine whether someone has touched or ingested class A drugs.

In a paper published in Royal Society of Chemistry’s Analyst journal, the consortium reveal how they have been able to identify the differences between the fingerprints of people who touched cocaine compared with those who have ingested the drug—even if the hands are not washed. The science behind the advance is the spectrometry imaging tools applied to the detection of cocaine and its metabolites in fingerprints.

In 2020 researchers were able to determine the difference between touch and ingestion if someone had washed their hands prior to giving a sample. Given that a suspect at a crime scene is unlikely to wash their hands before leaving fingerprints, these new findings are a significant advantage to crime forensics.

May 19, 2021

Google AI tool can help patients identify skin conditions

Posted by in categories: biotech/medical, robotics/AI

The tech giant says its “dermatology assist” tool can recognise 288 different skin ailments.

May 19, 2021

Eating a Western Diet Impairs the Immune System in the Gut – May Increase Risk of Inflammation, Infection

Posted by in category: biotech/medical

“This was a short-term experiment, just eight weeks,” Liu said. “In people, obesity doesn’t occur overnight or even in eight weeks. People have a suboptimal lifestyle for 20, 30 years before they become obese. It’s possible that if you have Western diet for so long, you cross a point of no return and your Paneth cells don’t recover even if you change your diet. We’d need to do more research before we can say whether this process is reversible in people.”


Eating a Western diet impairs the immune system in the gut in ways that could increase risk of infection and inflammatory bowel disease, according to a study from researchers at Washington University School of Medicine in St. Louis and Cleveland Clinic.

The study, in mice and people, showed that a diet high in sugar and fat causes damage to Paneth cells, immune cells in the gut that help keep inflammation in check. When Paneth cells aren’t functioning properly, the gut immune system is excessively prone to inflammation, putting people at risk of inflammatory bowel disease and undermining effective control of disease-causing microbes. The findings, published today (May 18, 2021) in Cell Host & Microbe, open up new approaches to regulating gut immunity by restoring normal Paneth cell function.

Continue reading “Eating a Western Diet Impairs the Immune System in the Gut – May Increase Risk of Inflammation, Infection” »

May 18, 2021

Commentary: Giving COVID survivors just one dose of the vaccine could help end the pandemic faster

Posted by in category: biotech/medical

Giving COVID survivors just one dose of the vaccine could help end the pandemic faster In South Korea, an analysis that included more than 500000 people age 60 and older found that the Pfizer vaccine was 89% effective in preventing infection just two weeks after the first shot. AstraZeneca’s vaccine, which has not been authorized for emergency use in the U.S., was found to be 86% effective in that same time period. Again, that’s after a single dose, and it’s regardless of prior COVID history.


Commentary: Getting a second dose of Pfizer or Moderna’s coronavirus vaccine might not be necessary for COVID survivors.

May 18, 2021

Human tissue preserved since World War I yields new clues about 1918 pandemic

Posted by in categories: biotech/medical, materials

On 27 June 1918, two young German soldiers—one age 18, the other 17—died in Berlin from a new influenza strain that had emerged earlier that year. Their lungs ended up in the collection of the Berlin Museum of Medical History, where they rested, fixed in formalin, for 100 years. Now, researchers have managed to sequence large parts of the virus that infected the two men, giving a glimpse into the early days of the most devastating pandemic of the 20th century. The partial genomes hold some tantalizing clues that the infamous flu strain may have adapted to humans between the pandemic’s first and second waves.

The researchers also managed to sequence an entire genome of the pathogen from a young woman who died in Munich at an unknown time in 1918. It is only the third full genome of the virus that caused that pandemic and the first from outside North America, the authors write in a preprint posted on bioRxiv.

“It’s absolutely fantastic work,” says Hendrik Poinar, who runs an ancient DNA lab at McMaster University. “The researchers have made reviving RNA viruses from archival material an achievable goal. Not long ago this was, like much ancient DNA work, a fantasy.”